James P. Zidar, MD

Commentary

IAGS 2002 Proceedings: Resolving Existing Restenosis (Part I of II)

08/01/2008

Hall Whitworth: We have performed about 350 cases at our center and it has evolved somewhat over the last couple of years. Initially, we used the CheckMate system because of its greater length. The pullback and stepping techniques have...

Hall Whitworth: We have...

08/01/2008

Journal of Invasive Cardiology

Review

Pharmacoinvasive Management of Acute Coronary Syndrome in the Setting of Percutaneous Coronary Intervention: Evidence-Based, Sit

08/01/2008

Dean J. Kereiakes , MD, FACC, FSCAI;

Jose G. Diez , MD;

Edward T.A. Fry , MD;

James J. Ferguson III, MD;

James P. Zidar , MD;

Glenn N. Levine , MD;

James E. Tcheng , MD;

Deepak L. Bhatt , MD, MPH, FACC, FAHA, FESC, MSCAI;

Gideon Bosker , MD;

Gary L. Schaer , MD, FACC, FSCAI;

Part II of III - Continued TABLE 3 KEY (continued) 2) Unfractionated heparin(UFH) can be used as an alternative to enoxaparin. If UFH is used in the setting of PCI, activated clotting time (ACT) should be followed to achieve an appropriate...

Part II of III -...

08/01/2008

Journal of Invasive Cardiology

Commentary

IAGS 2002 Proceedings: Resolving Existing Restenosis (Part II of II)

08/01/2008

Luis de la Fuente ;

Hal Whitworth ;

James P. Zidar , MD;

Stefan Beyer-Enke ;

Peter Gonschior , MD;

Hall Whitworth: There is another subset of patients who will be asking for these new drug-coated stents: those with long, diffuse distal disease. We may decide to treat such patients medically, but they too will be clamoring for the new...

Hall Whitworth: There is another...

08/01/2008

Journal of Invasive Cardiology

Review

Pharmacoinvasive Management of Acute Coronary Syndrome in the Setting of Percutaneous Coronary Intervention: Evidence-Based, Sit

08/01/2008

James J. Ferguson III, MD;

James P. Zidar , MD;

Glenn N. Levine , MD;

James E. Tcheng , MD;

Deepak L. Bhatt , MD, MPH, FACC, FAHA, FESC, MSCAI;

Gideon Bosker , MD;

Gary L. Schaer , MD, FACC, FSCAI;

Dean J. Kereiakes , MD, FACC, FSCAI;

Jose G. Diez , MD;

Edward T.A. Fry , MD;

A total of 5,225 patients were enrolled in the PARAGON B trial. Among these patients, the type of heparin used was known in 5,200 (99.5%). The median duration of therapy was 72.8 hours for UFH and 79.7 hours for LMWH. LMWH was used in about...

A total of 5,225 patients were...

08/01/2008

Journal of Invasive Cardiology

Commentary

IAGS Discussion ‚Äì Supporting Patients in Shock

08/01/2008

Luis de la Fuente ;

Howard A. Cohen , MD;

Gian Feltrin ;

Tom J. Linnemeier , MD;

Alfredo E. Rodriguez , MD, PhD;

James P. Zidar , MD;

Paul A. Overlie , MD, FACC, FACP;

Jeffrey Werner , MD;

Fayaz Shawl , MD;

Kirk N. Garratt , MD, MSc;

The High Mortality Among Patients in Cardiogenic Shock “LV or RV Infarcts:” What Have We Learned and Have We Made a Difference? In this symposium, we will revisit the treatment of cardiogenic shock complicating acute myocardial infarction...

The High Mortality Among...

08/01/2008

Journal of Invasive Cardiology

Education

Clinical Conference Proceedings: 15th Biennial International Andreas Gruentzig Society Meeting

05/28/2019

Molly Szerlip , MD, FACP;

D. A. Wood ;

H. Vernon Anderson , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

R. M. Bersin ;

Amir Lerman , MD;

J. Dawn Abbott , MD;

James P. Zidar , MD;

Ted A. Bass , MD;

Tarek A. Helmy , MD;

Douglas M. Cavaye , MD;

Herbert D. Aronow , MD, MPH, FACC, FSCAI;

Augusto D. Pichard , MD, FACC, FSCAI;

Eric J. Dippel , MD;

Srihari S. Naidu , MD;

G. S. Hanzel ;

Mauricio G. Cohen , MD, FACC;

Ayman A. Magd , MD;

Larry S. Dean , MD, FACC, FAHA, FSCAI;

J. Jeffrey Marshall , MD;

Kirk N. Garratt , MD, MSc;

A. Medigo ;

Michael J. Rinaldi , MD, FACC, FSCAI;

Michael R. Mooney , MD;

B. O'Neil ;

Paul Sorajja , MD;

Adam B. Greenbaum , MD;

The International Andreas Gruentzig Society is an educational society of physicians and scientists interested in cardiovascular and related fields. Members cooperate in the advancement of knowledge and education through research, publication,...

The International Andreas...

05/28/2019

Journal of Invasive Cardiology

Extensive Thrombus of Distal Anastomosis of Saphenous
Vein Graft

08/01/2008

Larry J. Diaz-Sandoval , MD;

John G. Webb , MD;

Ik-Kyung Jang , MD, PhD;

James P. Zidar , MD;

Javier Martín de la Torre , MD;

Rosana Hernandez-Antolin , MD, PhD;

David R. Ramsdale , FRCP, MD, BSc, MBChB;

Dominick J. Angiolillo , MD, PhD;

Case Report. The patient was a 76-year-old male with the cardiovascular risk factors of hypertension and hyperlipidemia. His cardiovascular history began in April 2000, with a myocardial infraction (MI) of the anteroseptal wall; although, he...

Case Report. The patient was a...

08/01/2008

Journal of Invasive Cardiology

Commentary

IAGS discussion ‚Äì Supporting Patients in Shock (Part ii)

08/01/2008

Jeffrey Werner , MD;

Howard A. Cohen , MD;

Luis de la Fuente ;

Gian Feltrin ;

Alfredo E. Rodriguez , MD, PhD;

Tom J. Linnemeier , MD;

James P. Zidar , MD;

Paul A. Overlie , MD, FACC, FACP;

Fayaz Shawl , MD;

Kirk N. Garratt , MD, MSc;

Part ii Continuation of discussion Supporting Patients in Shock Jeff Werner: I have a question for Dr. Shawl. I believe you said that you think patients should be completely revascularized during acute infarction using angioplasty and...

Part ii Continuation of...

08/01/2008

Journal of Invasive Cardiology

8.2 Drug Delivery for BTK Interventions: Which Drug and What Platform Will Get the Job Done?

07/21/2022

James P. Zidar , MD;

These proceedings summarize the educational activity of the 16th Biennial Meeting of the International Andreas Gruentzig Society held January 31-February 3, 2022 in Punta Cana, Dominican Republic Faculty Disclosures   ...

These proceedings summarize the...

07/21/2022

Journal of Invasive Cardiology

The Bifurcation Stent

08/01/2008

James P. Zidar , MD;

Michael H. Sketch Jr., MD;

Abdul R. Halabi , MD;

Case study. A 73-year-old female with no previous cardiac history presented with a history of crescendo chest pain over the last six weeks. Her symptoms were relieved by rest and nitroglycerin. Her risk factors included type-2 diabetes...

Case study. A 73-year-old...

08/01/2008

Journal of Invasive Cardiology